IOU YouTube: How can CTLA-4 play a role in long-term immunity?

Combining immunotherapies: inhibiting the CTLA-4 and PD-1 pathwaysПодробнее

Educational Sessions: "Understanding the anti-cancer immune response: Innate and adaptive..."Подробнее

IOU YouTube: How does CTLA-4 prevent T- cell activation?Подробнее

Cancer Immune Checkpoint InhibitorsПодробнее

Immunoregulation and T cell Tolerance with Arlene Sharpe, MD, PhDПодробнее

Anti-CTLA-4 Unleashing the Power of T Cells in Combination ImmunotherapyПодробнее

CTLA 4 inhibition new videoПодробнее

Challenges to Precision Medicine for Anti-Cancer ImmunotherapyПодробнее

CTLA-4: The Unwanted Player in CancerПодробнее

CTLA4 and attenuation of T cell responseПодробнее

Biomarkers of response to checkpoint inhibitors in untreated mNSCLCПодробнее

Beyond anti-PD-1 and anti-CTLA-4 in melanomaПодробнее

Symposium - Suzanne Topalian: Harnessing the Immune System to Treat CancerПодробнее

Media CTLA 4 InhibitionПодробнее

Novel Immunotherapies and CombinationsПодробнее

The benefits of CTLA-4 treatmentПодробнее

Immunotherapy For NSCLC | Immune Checkpoint Inhibitors | CTLA-4 Inhibitors |Подробнее

CTLA-4 breakdownПодробнее

The benefits of CTLA-4 treatmentПодробнее

Anti-PD-1 or anti-CTLA-4 in first line therapy?Подробнее

Immunotherapy for Melanoma, Pt. 2: Immune Checkpoints & the Drugs That Block ThemПодробнее